Top Health Tech Companies in Toronto (165)
Cencora is a leading pharmaceutical solutions organization centered on improving the lives of people and animals everywhere. With 46,000+ global team members, we have the opportunity to make a positive impact on healthcare in communities everywhere. Our team members are empowered to activate their careers through a collective of tools and resources designed to support individual career interests and...
Cencora's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue has risen across multiple periods, including fiscal 2025 up about 9% to roughly $321 billion and mid‑single‑digit year‑over‑year increases in fiscal 2026 quarters. Disclosures also note Q4 FY2025 revenue of $83.7 billion, up 5.9% year over year.
Profitability: Adjusted operating income and EPS expanded, with FY2025 adjusted EPS up 16% to $16.00 and Q2 FY2026 GAAP EPS rising to $8.40 alongside a raised full‑year adjusted EPS outlook to about $17.70–$17.90. Management also indicated double‑digit adjusted operating income growth expected for FY2026.
Resilient & Sustainable Growth: Momentum spans FY2023–FY2026 to date, with revenue progressing from about $262 billion (FY2023) to $294 billion (FY2024) to $321 billion (FY2025) and continued gains in 2026. Portfolio refocusing and acquisitions in specialty care (e.g., Retina Consultants of America, OneOncology) are described as engines supporting ongoing expansion and margin mix.
EliseAI builds vertical AI agents for housing and healthcare — sectors that together make up nearly 40% of household spending. These agents automate high-volume workflows like leasing, maintenance, renewals, and patient intake, helping organizations cut costs, improve efficiency, and deliver better experiences. How does it work? EliseAI integrates directly into operational workflows: Housing: Manages leasing, maintenance, renewals, billing, and resident communication. Healthcare: Handles intake,...
EliseAI's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Large late-stage financing and valuation momentum signal strong access to capital, including a $250M Series E and corroborated unicorn-scale valuations. Capital depth is further reinforced by indications of continued fundraising interest.
Strategic Partnerships: Embedded distribution with Zillow Rentals’ AI Assist, powered by EliseAI, is reported to drive higher renter engagement and application behavior. Such channel access expands reach and evidences measurable impact in real-world funnels.
Strong Revenue Growth: Company disclosures indicate surpassing $200M in ARR with continued acceleration from earlier milestones. Adoption signals across large operators align with sustained top-line expansion.
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Market Expansion: Headcount and footprint are described as rising to more than 15,000 employees across 40-plus offices, alongside concrete new sites in Hyderabad and a completed Chicago buildout—signals of geographic and capacity expansion. These moves indicate confidence in demand across key delivery hubs.
Innovation-Driven Growth: A dedicated Platforms & Products unit, the ZAIDYN portfolio, and AI-agent initiatives point to sustained investment in productized, AI-enabled offerings. Capability-deepening acquisitions (Digital Additive in 2024 and Torrent Consulting in 2025) further strengthen CRM and multi‑cloud life‑sciences solutions.
Strategic Partnerships: An expanded Salesforce collaboration around Agentforce and recognition as Databricks 2025 Life Sciences Partner of the Year suggest momentum in data/AI ecosystems. These alliances position the firm to capture spend where CRM, data, and AI converge in healthcare and life sciences.
We bring together clinical expertise, always-on tools, and deep insights so clients can improve their lives, providers can build practices they're proud of, and businesses can offer more effective, more efficient care. We believe mental health is a never-ending pursuit, and we build toward that progress every day. For our team, that means a day's work can literally change someone's life....
Grow Therapy's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Late-stage funding rounds—an $88M Series C (2024) and a $150M Series D (2026) led by top-tier firms at a roughly $3B valuation—provide runway for hiring, product development, and broader go-to-market. Feedback suggests this capital base signals strong sponsor conviction and supports continued scaling.
Strong Revenue Growth: Coverage highlights revenue rising from low single-digit millions in 2021 to hundreds of millions by 2024, with subsequent reports indicating around $1B in 2025 alongside surging appointment volumes. Inclusion on the FT/Statista fastest‑growing list reinforces the trajectory.
Market Expansion: Expansion to 125+ insurer partnerships, a nationwide network of roughly 26,000 providers, and new channels with employers and health systems indicate broader distribution. Rising utilization—7M visits in 2025 and 10M lifetime appointments—supports an expanding footprint.
At XGC Software Inc., our mission is to drive shareholder value by revolutionizing carbon credit management through our innovative xgcERP system. We are committed to transforming the carbon credit industry with a focus on transparency, efficiency, and regulatory compliance. Our advanced platform leverages blockchain technology to ensure that every carbon credit transaction is secure, traceable, and compliant with the highest...
Novel Biotechnology is a Synthetic Biology company focused on developing highly productive pDNA manufacturing platform. We also provide CRDMO and plasmid DNA manufacturing services to our clients
At PocketHealth, we’re on a mission to empower every patient with instant access, control and understanding of their health records, while streamlining medical image sharing for healthcare providers. We’ve built an easy-to-use platform that ensures medical images get where they need to go, without relying on legacy image exchange systems, CDs or portals. By eliminating the need for networks, we...
Ritual is a direct-to-consumer health brand that wasn't satisfied with the vitamin industry, so we challenged some of the top scientists to dream up the perfect daily vitamin. We believe it’s crucial to know not just what you’re putting into your body, but why you need it in the first place. Welcome to your new daily ritual!
Ritual's Top Stability & Growth Strengths
Strong Revenue Growth: Reported results indicate the company surpassed $250 million in 2024 retail sales and continues adding national retailers, pointing to sustained top-line momentum. Serving over two million customers and significant unit volume further underscores scale.
Market Expansion: The brand has expanded from a subscription DTC model into major national retailers such as Whole Foods, Target, Amazon, Ulta, Walmart, and select Costco locations. This omnichannel footprint broadens reach and diversifies distribution.
Customer Loyalty & Retention: Company disclosures highlight a large customer base with strong repeat purchasing and leading positions for key SKUs like its Essential Prenatal across major channels. Such retention signals support predictable recurring revenue in subscriptions and retail.
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together...
Syneos Health's Top Stability & Growth Strengths
Strong Market Position & Advantage: Company materials and third‑party recognition portray a fully integrated CRO/CCO with leadership status, including widespread involvement in recent FDA/EMA novel therapies and recognition as a leading pharmacovigilance provider.
Strategic Partnerships: Recent collaborations with Microsoft and KX are positioned to enable AI‑driven efficiencies across clinical and commercial operations, with reported improvements in cycle times supporting operational scalability.
Investor Backing & Capital Strength: The 2025 take‑private by investment groups (including Elliott and Veritas) provides financial sponsorship to pursue tech‑enabled growth and operational repositioning.
Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the...
Insulet's Top Stability & Growth Strengths
Strong Revenue Growth: Company reported accelerating revenue growth across 2024–2025 and guided continued double‑digit expansion for 2026. Quarterly updates highlighted broad‑based momentum in both U.S. and international markets.
Strong Market Position & Advantage: Omnipod leads the tubeless/patch‑pump segment and ranked No. 1 in new customer starts in the U.S. and Europe in 2024–2025, reinforcing competitive momentum. First‑to‑market AID clearance for adults with type 2 diabetes and broad CGM integrations bolster positioning.
Market Expansion: International rollouts and expansion into type 2 diabetes materially increased the addressable market and active user base. Added manufacturing capacity in Malaysia supports global demand and cost scaling.
We believe best-in-class care requires outstanding medicine and manner. That’s why we offer the latest fertility advancements and expertise, paired with a personalized, whole-person approach to care – at each step and to everyone we serve. We’re more than practitioners of medicine, we are trusted partners on the journey
University Health Network is Canada's largest research hospital and a public research and teaching hospital network in Toronto, Ontario, known for its scope of research and complexity of cases.
AmerisourceBergen fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies and providers, we create unparalleled access, efficiency and reliability for human and animal health. Our 41,000 global...
As a strategic partner to some of the world’s largest healthcare organizations, we play a deep and meaningful role in accelerating digital innovation, driving sustainable value and helping improve outcomes across the healthcare ecosystem. With our deep healthcare domain knowledge and next-generation technology focus, we are well positioned to build digital capabilities and specialized platforms, enabling healthcare organizations reinvent themselves...
Modern technology enables new digital experiences and Mozzaz is on a mission to deploy solutions that create collaborative, personalized care plans for all patients and programs. Our digital health platform provides extensive solutions for virtual health, secure telehealth, remote patient management and interactive patient engagement. By taking a consultative approach to digital health and the virtual care ecosystem, Mozzaz is...
Dialogue is a leading virtual care provider that empowers organizations to build healthier, happier, and more productive teams. Our high-touch health and well-being programs provide organizations and their members with tailored, measurable, and quality clinical care. Dialogue's team of health professionals delivers exceptional experiences across the continuum of care, positively impacting millions worldwide. We foster thriving teams focused on health...
Jack Nathan Health is on a mission to provide accessible quality healthcare services through its network of medical clinics, located inside Walmart stores throughout Canada and Mexico. With Jack Nathan Health, people have direct access to accredited healthcare professionals through in-clinic visits, instant referrals, and telemedicine options. With access to on-site pharmacy, groceries other retail and ample parking, Jack Nathan...
For more than 50 years, Extendicare’s qualified and experienced teams have been helping people live better through a commitment to quality care and service that includes skilled nursing care, home health care and management and consulting services. We are proud to be at the forefront of senior care across Canada and work closely with government, community agencies, researchers, and our care...
.png)
At RLDatix, we believe that what flows through our software is more than bits and bytes — it’s human lives. This is our mantra, our mindset, our passion and our purpose. We deliver comprehensive healthcare software solutions designed to raise the standard of care for patients, providers and healthcare organizations around the world. What sets us apart: ? Global reach, local impact —...
RLDatix's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is widely recognized as a leader in healthcare safety, risk, and GRC, supported by industry rankings and adoption among top U.S. health systems. A large global installed base and a broad platform footprint reinforce durable competitive positioning.
Market Expansion: Customer reach has expanded materially through acquisitions and partnerships across regions and adjacent categories. Growth into workforce management, credentialing, and patient experience signals continued penetration beyond core patient safety and risk.
Investor Backing & Capital Strength: Major private equity sponsors and new growth investment provide resources for organic initiatives and M&A. Access to significant refinancing capacity further supports ongoing expansion plans.
CorVista Health is applying machine learning to develop a novel cardiac diagnostic platform, CorVista® System, with the aim of transforming cardiovascular care and the patient experience. The CorVista System is a non-invasive, point-of-care solution that allows physicians to evaluate heart function without radiation, contrast agents, injections, fasting or exercise. For more information, visit www.corvista.com.
